The data reveals that 16 per cent of corporate employees are at an increased risk of developing cardiac disorders. Alarmingly, 31 per cent of those aged between 35 and 50 exhibit higher-than-normal cardiac risks for their age
Read More
In a letter addressed to the Ministry of Commerce, AiMeD highlighted a 68 per cent surge in imports of medical devices into India over the last four years, which has led to the country relying on imports for 70 per cent of its medical device needs
Read More
Prolonged stress keeps the body's "fight-or-flight" response activated, leading to continuous exposure to stress hormones
Read More
This expansion brings the total number of Redcliffe Labs' diagnostic centres in the state to over 20, with more than 500 collection points
Read More_20240924163448_original_image_3.webp)
The biopharma sector now accounts for 49 per cent of India's biotechnology output, with a consistent double-digit growth rate driven by government support, cutting-edge research, and skilled talent
Read More
According to the GLOBOCAN 2022 data, lung cancer is the fourth leading cause of cancer-related mortality in India. NSCLC accounts for a significant proportion of these cases, with about 15 per cent of patients having resectable disease, this data underscores the importance of targeted treatment options.
Read More_20240924135536_original_image_25.webp)
The Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies.
Read More
Already showing remarkable success in countries where it is available, this therapy harnesses the body’s own immune cells to target and destroy cancerous cells
Read More
The new CyberKnife S7 System offers a non-invasive treatment alternative for patients with tumors in various parts of the body, including the brain, lung, spine, prostate, and abdomen
Read More
